Building the

bioeconomy,

together.

A full-stack fermentation platform to enable biomanufacturing at scale. Planetary builds, owns, and operates a global network of facilities to produce your bio-based products — faster, cleaner, and at true commercial scale.

50+
Facilities worldwide
10×
Faster to market
90%
Lower CO₂
Services

Everything you need to scale bio-manufacturing

We are the full-stack fermentation platform — infrastructure, science, and operations under one roof.

🧫

Fermentation Infrastructure

Access our global network of GMP-certified fermentation facilities — from pilot scale to full commercial production — without the capital investment.

📈

Process Scale-Up

Our bioprocess engineers transfer your lab-proven strain directly into production. We handle optimisation, yield maximisation, and regulatory compliance.

🌍

Global Supply Chain

From a single facility to a multi-continent network, Planetary manages logistics, quality, and supply continuity so you can focus on your product.

🛡️

Regulatory & Quality

Navigate FDA, EFSA, and international bio-based regulations with confidence. Our QA teams embed into your project from day one.

📊

Techno-Economic Analysis

Before you commit capital, we model your cost of goods, carbon footprint, and breakeven scenarios across our entire facility network.

🤝

Dedicated Partnership

A named Planetary team is embedded with yours throughout the project — from strain delivery to first commercial batch and beyond.

How It Works

From strain to scale in four steps

01

Deliver your strain

You provide your engineered microorganism or production strain. Planetary handles all biosafety intake, characterisation, and stability testing.

02

Process transfer & optimisation

Our bioprocess engineers adapt your process to our bioreactor fleet. We run DoE campaigns to maximise titre, rate, and yield before scale-up.

03

Scale across our network

From a 500 L pilot run to a 200 000 L commercial campaign, we match your volume to the right facility at the right geography — reducing lead times by 10×.

04

Product in your hands

Downstream processing, QC release testing, and cold-chain logistics handled end-to-end. Your bio-based product arrives ready for your next step.

Impact

Proof that sustainable is scalable

The old argument that sustainability costs more is over. Fermentation at scale is already the most cost-competitive route to many bio-based molecules — and Planetary has built the infrastructure to prove it.

Request our impact report →
90%
Lower CO₂ vs petrochemical
Verified by third-party LCA across our full facility network
10×
Faster market entry
Compared to building your own fermentation plant from scratch
60%
Cost reduction on COGS
Through shared infrastructure, volume pooling, and process efficiency
50+
Facilities worldwide
Operating across Europe, North America, and Asia Pacific
Data & Growth

The numbers behind the network

Real production data from across our global facility network — updated quarterly.

Fermentation Capacity

Total installed capacity (kL) · 2020 – 2025

12k
2020
28k
2021
55k
2022
110k
2023
190k
2024
320k
2025
+26×capacity growth since 2020

Facilities by Region

Share of active production sites

50+facilities
Europe
42%
North America
31%
Asia Pacific
19%
Rest of world
8%

CO₂ Avoided vs Petrochemical Baseline

Cumulative kilotonnes of CO₂-equivalent saved · 2020 – 2025

Bio-based (Planetary)
Petrochemical baseline
05010015020020204kt202111kt202227kt202358kt2024104kt2025178kt
178kt
CO₂ avoided in 2025
380kt
Cumulative since 2020
90%
Vs petrochemical route
Projects

Production that speaks for itself

See all case studies →
Precision Fermentation

Animal-free dairy proteins at commercial scale

Partnered with a Swiss food-tech startup to scale their whey protein strain from 10 L flask to 50 000 L commercial batches in under 18 months.

50 000 L bioreactor18-month timelineEU regulatory approval
Industrial Biotech

Bio-based surfactants replacing petroleum derivatives

Enabled a global FMCG group to transition their surfactant supply chain from fossil-based to bio-based without interrupting production.

3 continents200 000 t/yearISCC PLUS certified
Pharmaceutical

API fermentation for GMP small-molecule production

Designed and operated a dedicated fermentation suite for a Phase III clinical API, delivering 99.9% batch success rate across 24 consecutive runs.

GMP compliant99.9% batch yieldFDA-ready dossier
Testimonials

What our partners say

Planetary compressed what would have been a 4-year construction project into an 18-month partnership. We were in commercial production while our competitors were still pouring concrete.

Dr. Sophie Meier
CEO, AlphaFerm AG

Their bioprocess team understood our strain constraints better than our own CTO after the first week. The yield improvements they unlocked saved us $4M in the first production campaign alone.

James Lindqvist
VP Operations, BioNord

We needed GMP-grade production in three countries simultaneously. Planetary orchestrated all three sites with the same quality standard. I still don't know how they pulled it off.

Clara Vasquez
Head of Manufacturing, Cellativa
About

We saw the missing piece of the bioeconomy

In 2019, every breakthrough in synthetic biology hit the same wall: no one would build the factory. Startups with world-class strains were spending years and hundreds of millions on infrastructure instead of on their products.

Planetary was founded to fix that. We raised the capital, built the facilities, and assembled the operational team so that every biotech innovator — from seed-stage to Fortune 500 — can access world-class fermentation capacity on demand.

Today we operate a network spanning three continents, producing everything from precision-fermented food proteins to pharmaceutical APIs to industrial enzymes. Our mission is simple: make bio-based production so accessible it becomes the default.

Leadership team

LH
Dr. Lena Hoffmann
Co-Founder & CEO

Former Head of Fermentation at Novartis. PhD in Biochemical Engineering, ETH Zürich.

MC
Marcus Chen
Co-Founder & CTO

Built large-scale bioprocess platforms at Ginkgo Bioworks and Zymergen. MSc MIT.

PN
Priya Nair
CFO

15 years in biotech infrastructure finance. Previously VP at EQT Life Sciences.

TG
Dr. Tobias Gruber
Chief Science Officer

Author of 40+ peer-reviewed papers in synthetic biology and fermentation optimisation.

Contact

Ready to scale?

Tell us about your product and strain. We will respond within one business day with an initial feasibility assessment — no NDA required for first contact.

📍
Headquarters
Basel, Switzerland
✉️
Email
hello@planetarygroup.ch
🌐
Web
www.planetarygroup.ch